Resources & Reports

Reports

Medicaid & Telehealth: Summary and Findings from the Spring Webinar Series

CCHP recently completed and released a report summarizing the four webinars hosted during the Spring Telehealth & Medicaid webinar series. The purpose of the Spring Series was to examine specific areas of telehealth policy and their impacts on particular patient populations. The report dives into the findings gleaned from the presentations and synthesizes key takeaways from each Medicaid agency’s telehealth policy activities.

Reports

Telehealth & Medicaid: A Policy Webinar Series – Winter Webinar Series Report

CCHP recently completed and released a report summarizing the four webinars hosted during the Winter webinar series. The Winter series theme, Telehealth Policy and COVID-19, focused on the rapid telehealth policy developments prompted by the public health emergency (PHE). The report dives into the findings gleaned from the presentations and synthesizes key takeaways from each Medicaid agency’s COVID-19 telehealth policy activities.

Reports

An Analysis of Private Payer Telehealth Coverage During the COVID-19 Pandemic

This report builds on CCHP’s COVID-19 research and resources by detailing the efforts that major U.S. health insurance carriers took to expand telehealth access in response to the pandemic. The eligibility windows for these policy changes ranged from March 2020 through the end of the public health emergency (PHE). We focused our analysis on private payer policies that were implemented prior to November 25, 2020. The report provides an overview of the key findings from our analysis and discusses their implications.

Reports

Barriers & Challenges to FQHC Use of Telehealth for Substance Use Disorder

CCHP has released an issue brief on its research funded by the National Institute of Health Care Management (NIHCM) into the policy changes that need to be made in order for federally qualified health centers (FQHCs) to utilize telehealth to address the opioid crisis.  This issue brief provides a comparison of reimbursement and prescribing policies both prior to and following the onset of the COVID-19 emergency.